samedan logo

 
 
spacer
home > white papers > Quality By Design - Biopharma Group
WHITE PAPERS
logo_Biopharma_.jpg

Biopharma Group

phone +44 (0)1962 841092
email bps@biopharma.co.uk
web http://www.biopharma.co.uk
email Head Office, Biopharma House, Winnall Valley Road, Winchester SO23 0LD

Quality By Design

Quality by Design (QbD) is a systematic approach to development that begins with the defined objectives and emphasizes science and quality risk management in order to achieve those goals. QbD ensures that the quality of the product is built into production processes from the outset, rather than being tested after development has already commenced.
Quality By Design
spacer

Member login

E-mail address:

Password:
Remember me


News and Press Releases

Coriolis Pharma and U-Medico Announce a Strategic Alliance

MARTINSRIED, Germany and OSAKA, Japan, March 17, 2022 / B3C newswire / -- Coriolis Pharma, a globally operating service provider and one of the world leaders in formulation research and development of (bio)pharmaceutical drugs located in Germany, and U-Medico, an innovative formulation development and biophysical characterisations service provider located in Japan, today announce a strategic alliance that includes an equity investment by Coriolis Pharma into U-Medico.
More info >>


White Papers

Pandemic respiratory vaccine clinical trials: a departure from business as usual

ICON plc

Around the world, the “V” words are on everyone’s lips: Virus and Vaccines. In response to the urgent need for a vaccine for COVID-19, researchers are, at time of publication, running 500+ clinical trials (and counting) on a number of antivirals, antibodies and vaccines. Promising possibilities range from novel new drugs/vaccines, repurposing treatments currently indicated for HIV, Ebola and malaria, to monoclonal antibodies and immune serum.
More info >>



©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement